Improved efficacy of naproxen-loaded NLC for temporomandibular joint administration.

Author: AbdallaHenrique B, AlcântaraAna C S, BonfanteRicardo, BreitkreitzMárcia C, CastroSimone R, CeredaCintia M S, Clemente-NapimogaJuliana, GuilhermeViviane A, MacedoCristina G, RibeiroLígia N M, Rodrigues da SilvaGustavo H, da SilvaCamila Gonçalves, de PaulaEneida

Paper Details 
Original Abstract of the Article :
Inflammatory conditions of the temporomandibular joint (TMJ) and peripheral tissues affect many people around the world and are commonly treated with non-steroidal anti-inflammatory drugs (NSAIDs). However, in order to get desirable results, treatments with NSAIDs may take weeks, causing undesirable...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6673697/

データ提供:米国国立医学図書館(NLM)

Naproxen-Loaded NLCs: Delivering Relief to the Temporomandibular Joint

The temporomandibular joint (TMJ), a complex structure that connects the jaw to the skull, can be a source of significant pain and discomfort. Conditions like TMJ disorders can make chewing, talking, and even sleeping a challenge. Researchers are constantly seeking new and effective ways to deliver pain relief to the TMJ.

This research team, like architects designing a new bridge, aimed to develop a nanostructured lipid carrier (NLC) formulation to deliver naproxen (NPX), a common non-steroidal anti-inflammatory drug (NSAID), directly to the TMJ. They carefully crafted a formulation that provided sustained delivery of NPX, reducing inflammation and pain in a rat model of TMJ inflammation. The researchers found that the NLC-NPX formulation effectively reduced leukocyte migration and the levels of pro-inflammatory cytokines, providing prolonged pain relief.

A New Bridge to Relief: Targeted Delivery of Naproxen for TMJ Pain

This study offers a potential breakthrough in TMJ pain management. The researchers’ findings suggest that the NLC-NPX formulation could provide targeted delivery of NPX, offering prolonged pain relief and reducing the need for frequent administration. This approach could be a significant improvement over conventional NSAID treatments.

Building a Stronger Foundation: New Approaches for TMJ Pain Relief

This research highlights the importance of developing new and innovative approaches to treating TMJ pain. The study’s findings suggest that NLC-NPX could be a valuable tool for providing targeted and sustained pain relief, improving the quality of life for those suffering from TMJ disorders.

Dr.Camel's Conclusion

This study’s findings offer a glimmer of hope for those suffering from TMJ pain. The researchers’ innovative approach to targeted drug delivery holds the potential to revolutionize TMJ pain management, offering a bridge to long-lasting relief.

Date :
  1. Date Completed 2020-11-05
  2. Date Revised 2021-01-10
Further Info :

Pubmed ID

31371737

DOI: Digital Object Identifier

PMC6673697

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.